🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT06595043
Recruiting Not applicable

Effects of Different Occlusion Angles of Disposable Tracheal Blocker on Right One-lung Ventilation

NCT06595043 · tracked via the Priya Life Science China tracker
Sponsor
China Medical University, China
Phase
Not applicable
Started
2024-10-09
Last updated
2024-09-19

Condition(s) studied

The Direction of Blocker Placement

Investigational drug(s) / intervention(s)

the tip opening angle to the leftthe tip opening angle to the right

the tip opening angle to the left: After fixing the position of the tracheal catheter, the opening of the tip of the blocker will be adjusted to left under the guidance of the fiber bronchoscope.

the tip opening angle to the right: After fixing the position of the tracheal catheter, the opening of the tip of the blocker will be adjusted to right under the guidance of the fiber bronchoscope.

Study summary

This trial is a practical, multicenter, prospective, parallel grouping, randomized controlled,two-arm study. This study will be conducted in three centers including the First Hospital of China Medical University, Seoul National University Hospital and the University Clinical Center of Serbia. The investigators aim to investigate the effect of different occlusion angles of disposable tracheal blocker on right one-lung ventilation

Eligibility

Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
No
Inclusion Criteria: * Age ranged from 18 to 65 years old; * American Society of Anesthesiologists (ASA) grade I-III; * No history of drug allergy or abnormal anesthesia; * Patients undergoing right thoracoscopic surgery; * The preoperative oxygen saturation was not less than 94%. Exclusion Criteria: * Patients with a history of acute lung injury or ARDS within 3 months; * Cardiac function class IV (New York Heart Association classification); * Chronic renal failure (renal cell filtration rate \<30ml min-11.73m-2), severe liver disease; * Patients with blurred consciousness and cognitive dysfunction; * Patients with severe coagulation dysfunction; * Without preoperative oxygen inhalation, blood oxygen \<94%, severe pulmonary dysfunction; * Patients with endotracheal tube admitted to ICU after operation; * Body mass index (BMI) \>30; * Patients who had had lung surgery; * Inability to complete the study;

Primary outcome measure(s)

Trial sites (3)

FacilityCityRegionStatus
Wenfei Tan Shenyang China Recruiting
the University Clinical Center of Serbia Belgrade Serbia Not Yet Recruiting
Konkuk University School of Medicine Seoul South Korea Not Yet Recruiting

More China Medical University, China trials in China

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06595043 on ClinicalTrials.gov ↗ ← All trials in China